See more : Electrovaya Inc. (ELVA) Income Statement Analysis – Financial Results
Complete financial analysis of Karolinska Development AB (publ) (KDEVF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Karolinska Development AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- DeTai New Energy Group Limited (0559.HK) Income Statement Analysis – Financial Results
- Evoq Remedies Limited (EVOQ.BO) Income Statement Analysis – Financial Results
- Daedong Corporation (000490.KS) Income Statement Analysis – Financial Results
- Microwave Chemical Co., Ltd. (9227.T) Income Statement Analysis – Financial Results
- Mercari, Inc. (MCARY) Income Statement Analysis – Financial Results
Karolinska Development AB (publ) (KDEVF)
About Karolinska Development AB (publ)
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.81M | 2.30M | 2.17M | 2.65M | 3.38M | 3.07M | 2.46M | 5.36M | 2.94M | 5.03M | 9.94M | 9.94M | 10.48M | 13.90M | 30.32M | 2.32M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 2.81M | 2.30M | 2.17M | 2.65M | 3.38M | 3.07M | 2.46M | 5.36M | 2.94M | 5.03M | 9.94M | 9.94M | 10.48M | 13.90M | 30.32M | 2.32M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.42M | 15.36M | 16.45M | 36.02M | 108.98M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 21.83M | 26.59M | 23.21M | 23.62M | 24.19M | 0.00 | 0.00 | 15.42M | 15.36M | 16.45M | 36.02M | 108.98M | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | -3.92M | -91.05M | 187.15M | -195.40M | -18.19M | -14.02M | -13.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 3.92M | 34.07M | 30.78M | 32.78M | 42.36M | 29.01M | 36.51M | 32.87M | 46.74M | 68.59M | 115.14M | 176.96M | 411.15M | 359.16M | 43.78M | 10.07M |
Cost & Expenses | 4.72M | 34.07M | 30.78M | 32.78M | 42.36M | 29.01M | 36.51M | 32.87M | 46.74M | 68.59M | 115.14M | 176.96M | 411.15M | 359.16M | 43.78M | 10.07M |
Interest Income | 7.30M | 1.42M | 6.41M | 908.00K | 1.95M | 7.32M | 4.55M | 1.95M | 2.46M | 637.00K | 5.92M | 5.83M | 6.25M | 3.97M | 414.00K | 1.02M |
Interest Expense | 0.00 | 844.00K | 6.28M | 5.69M | 32.39M | 49.46M | 43.50M | 45.24M | 40.06M | 4.00K | 72.00K | 57.00K | 36.00K | 22.00K | 19.00K | 424.00K |
Depreciation & Amortization | 798.00K | 690.00K | 690.00K | 690.00K | 704.00K | -94.05M | -251.98M | 106.00K | 212.00K | 212.00K | 2.63M | 5.16M | 3.43M | 27.42M | 1.46M | 767.00K |
EBITDA | -26.78M | -86.59M | -27.92M | -201.11M | -38.28M | -20.01M | -31.47M | -171.49M | -1.01B | -371.27M | -157.15M | -270.75M | -402.19M | -311.84M | -1.17M | -4.58M |
EBITDA Ratio | -39.65% | -1,290.09% | -530.83% | -1,086.68% | -1,508.60% | -651.03% | -1,276.99% | -463.25% | -1,178.01% | -1,279.26% | -952.40% | -1,602.30% | -3,838.09% | -2,244.27% | -3.85% | -197.07% |
Operating Income | -1.91M | -87.42M | 160.70M | -202.43M | 347.94M | 74.04M | 220.51M | -174.05M | -1.02B | -372.22M | 144.28M | -253.81M | -405.62M | -345.26M | -13.46M | -7.05M |
Operating Income Ratio | -68.08% | -3,800.91% | 7,405.53% | -7,635.84% | 10,281.94% | 2,409.47% | 8,949.27% | -3,247.18% | -34,680.08% | -7,399.92% | 1,451.47% | -2,552.65% | -3,870.83% | -2,484.81% | -44.40% | -303.79% |
Total Other Income/Expenses | 8.89M | -701.00K | 10.12M | -5.06M | -44.96M | -43.53M | -40.92M | -42.78M | -34.39M | -3.60M | 41.43M | -22.16M | -4.99M | 5.98M | 10.82M | 1.29M |
Income Before Tax | 5.39M | -88.12M | 170.82M | -207.49M | 302.98M | 30.51M | 179.60M | -216.83M | -1.05B | -375.82M | 185.17M | -275.97M | -405.66M | -339.28M | -2.64M | -5.77M |
Income Before Tax Ratio | 191.88% | -3,831.39% | 7,871.84% | -7,826.74% | 8,953.22% | 992.84% | 7,288.76% | -4,045.37% | -35,848.84% | -7,471.47% | 1,862.84% | -2,775.53% | -3,871.17% | -2,441.75% | -8.71% | -248.36% |
Income Tax Expense | 0.00 | 57.06M | -172.91M | 172.93M | -399.70M | 0.00 | 0.00 | 149.11M | 985.42M | 307.66M | -2.93M | -45.81M | -19.99M | -4.70M | 10.84M | 1.71M |
Net Income | 5.39M | -88.12M | 170.82M | -207.49M | 302.98M | 30.51M | 179.60M | -216.83M | -1.05B | -375.82M | 197.16M | -212.85M | -385.67M | -334.58M | -2.64M | -5.77M |
Net Income Ratio | 191.88% | -3,831.39% | 7,871.84% | -7,826.74% | 8,953.22% | 992.84% | 7,288.76% | -4,045.37% | -35,848.84% | -7,471.47% | 1,983.53% | -2,140.72% | -3,680.44% | -2,407.95% | -8.71% | -248.36% |
EPS | 0.02 | -0.34 | 0.86 | -1.05 | 3.63 | 0.42 | 2.59 | -3.61 | -17.57 | -6.85 | -2.88 | -3.88 | -7.78 | -8.91 | -0.09 | -0.21 |
EPS Diluted | 0.02 | -0.34 | 0.86 | -1.05 | 3.63 | 0.42 | 2.59 | -3.61 | -17.57 | -6.85 | -2.88 | -3.88 | -7.78 | -8.91 | -0.09 | -0.21 |
Weighted Avg Shares Out | 269.83M | 257.42M | 198.10M | 198.10M | 83.42M | 72.43M | 69.16M | 60.09M | 60.02M | 54.89M | 54.60M | 54.80M | 49.58M | 37.56M | 30.49M | 27.85M |
Weighted Avg Shares Out (Dil) | 269.83M | 257.42M | 198.10M | 198.10M | 83.42M | 72.43M | 69.22M | 60.09M | 60.02M | 54.89M | 54.60M | 54.80M | 49.58M | 37.56M | 30.49M | 27.85M |
Source: https://incomestatements.info
Category: Stock Reports